Preference Based Outcome Measures for Economic Evaluation of Drug Interventions
- 1 May 1992
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 1 (5) , 338-345
- https://doi.org/10.2165/00019053-199201050-00005
Abstract
Decisions about medical treatment and health programmes involve both technical and value judgements. For the purpose of performing an economic appraisal of different health interventions (including...Keywords
This publication has 22 references indexed in Scilit:
- Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decisionmaking about health care programs.1991
- Measuring the adverse effects of unnecessary hypertension drug therapy: QALYs vs HYE.1991
- QALYs and the equity-efficiency trade-offJournal of Health Economics, 1991
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- Clinical economics. A guide to the economic analysis of clinical practicesJAMA, 1989
- Quality-adjusted Life Years, Utility Theory, and Healthy-years EquivalentsMedical Decision Making, 1989
- The use of QALYs in health care decision makingSocial Science & Medicine, 1989
- Utility approach to measuring health-related quality of lifeJournal of Chronic Diseases, 1987
- Economics of coronary artery bypass grafting.BMJ, 1985
- Fallacy of the Five-Year Survival in Lung CancerNew England Journal of Medicine, 1978